Risperidone versus other atypical antipsychotic medication for schizophrenia
Introduction: Risperidone is one of a number of atypical antipsychotics that are currently being marketed for the treatment of people with schizophrenia, largely on the basis of claims of improved tolerability and effectiveness compared with much cheaper conventional antipsychotics. The efficacy of risperidone has already been compared with conventional drugs, but it remains unclear how risperidone compares with other atypical antipsychotic drugs, such as clozapine.